Pinnacle Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-473,350
| Closed | -$3.38M | – | 710 |
|
|
2020
Q1 | $3.38M | Sell |
473,350
-44,594
| -9% | -$318K | 0.1% | 199 |
|
|
2019
Q4 | $12.4M | Sell |
517,944
-36,535
| -7% | -$872K | 0.27% | 103 |
|
|
2019
Q3 | $14.9M | Buy |
554,479
+139,400
| +34% | +$3.74M | 0.35% | 77 |
|
|
2019
Q2 | $11.3M | Sell |
415,079
-25,884
| -6% | -$702K | 0.26% | 108 |
|
|
2019
Q1 | $15.3M | Buy |
440,963
+89,475
| +25% | +$3.1M | 0.35% | 83 |
|
|
2018
Q4 | $6.86M | Sell |
351,488
-5,827
| -2% | -$114K | 0.18% | 151 |
|
|
2018
Q3 | $9.52M | Sell |
357,315
-2,680
| -0.7% | -$71.4K | 0.2% | 139 |
|
|
2018
Q2 | $13.6M | Sell |
359,995
-65,621
| -15% | -$2.48M | 0.28% | 99 |
|
|
2018
Q1 | $13.9M | Sell |
425,616
-19,060
| -4% | -$623K | 0.27% | 97 |
|
|
2017
Q4 | $21.6M | Sell |
444,676
-47,705
| -10% | -$2.32M | 0.42% | 70 |
|
|
2017
Q3 | $26.6M | Sell |
492,381
-8,655
| -2% | -$468K | 0.49% | 61 |
|
|
2017
Q2 | $28.1M | Sell |
501,036
-25,140
| -5% | -$1.41M | 0.54% | 51 |
|
|
2017
Q1 | $20.6M | Sell |
526,176
-24,240
| -4% | -$950K | 0.39% | 72 |
|
|
2016
Q4 | $12.4M | Sell |
550,416
-30,520
| -5% | -$685K | 0.25% | 109 |
|
|
2016
Q3 | $13.2M | Sell |
580,936
-3,470
| -0.6% | -$78.8K | 0.26% | 104 |
|
|
2016
Q2 | $13.8M | Buy |
+584,406
| New | +$13.8M | 0.3% | 94 |
|